Thimerosal-Containing Vaccines and Autistic Spectrum Disorder: A Critical Review of Published Original Data

  title={Thimerosal-Containing Vaccines and Autistic Spectrum Disorder: A Critical Review of Published Original Data},
  author={Sarah K. Parker and Benjamin A. Schwartz and James Todd and Larry K. Pickering},
  pages={793 - 804}
Objective. The issue of thimerosal-containing vaccines as a possible cause of autistic spectrum disorders (ASD) and neurodevelopmental disorders (NDDs) has been a controversial topic since 1999. Although most practitioners are familiar with the controversy, many are not familiar with the type or quality of evidence in published articles that have addressed this issue. To assess the quality of evidence assessing a potential association between thimerosal-containing vaccines and autism and… 

Tables from this paper

[Addressing the controversy regarding the association between thimerosal-containing vaccines and autism].
The aim of this article is to review the literature for the main controversies about thimerosal in vaccines and its supposed association to autism, and concluded that the current available evidence do not support an association betweenThimerosal and childhood neurodevelopmental disorders, such as autism.
Mercury in vaccines: A review
It is not possible to prove that thiomersal is completely safe, but need of the hour is to eliminate or reduce this preservative in the background of the debate surrounding its safety.
Autistic spectrum disorder: No causal relationship with vaccines.
This article concludes that there are no data to support any association between immunization and ASD, and replaces the Canadian Paediatric Society's 2001 position statement on this topic.
Thiomersal-containing vaccines - a review of the current state of knowledge.
There are no contraindications to the use of vaccines with thiomersal in infants, children and non-pregnant women, and the risk of serious complications associated with the development of diseases in unvaccinated individuals far outweighs the potential risk of adverse consequences associated with immunization with thuomersal.
Nutritional and environmental approaches to preventing and treating autism and attention deficit hyperactivity disorder (ADHD): a review.
Larger studies are needed to determine optimum multifactorial treatment plans involving nutrition, environmental control,medication, and behavioral/education/speech/physical therapies.
Immunizations and Autism: A Review of the Literature
  • A. Doja, W. Roberts
  • Medicine
    Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
  • 2006
A literature review found very few studies supporting this theory, with the overwhelming majority showing no causal association between the Measles-Mumps-Rubella vaccine and autism.
Pharmacotherapy and Bumetanide in Autism Treatment
  • A. Kalkan
  • Biology
    Journal of Experimental and Basic Medical Sciences
  • 2020
The pharmacological treatment approaches of autism, the targeted new treatment mechanisms, the association between intracellular chloride concentration with autism are mentioned respectively, and bumetanide, one of the most studied chemicals in the past decade, is reviewed.
Thimerosal disappears but autism remains.
  • E. Fombonne
  • Psychology
    Archives of general psychiatry
  • 2008
In 2004, the Institute of Medicine Immunization Safety Review Committee reviewed all evidence available from epidemio-logic, biological, molecular, and animal model studies and concluded that the evidence favored the rejection of both hypotheses with respect to the risk of autism.


Association between thimerosal-containing vaccine and autism.
The results do not support a causal relationship between childhood vaccination with thimerosal-containing vaccines and development of autistic-spectrum disorders.
Neurodevelopmental Disorders after Thimerosal-Containing Vaccines: A Brief Communication
An association between neurodevelopmental disorders and thimerosal-containing DTaP vaccines was found, but additional studies should be conducted to confirm and extend this study.
Thimerosal Exposure in Infants and Developmental Disorders: A Retrospective Cohort Study in the United Kingdom Does Not Support a Causal Association
With the possible exception of tics, there was no evidence that thimerosal exposure via DTP/DT vaccines causes neurodevelopmental disorders.
An assessment of the impact of thimerosal on childhood neurodevelopmental disorders
The evidence presented here shows that the occurrence of neurodevelopmental disorders following thimerosal-containing childhood vaccines does not appear to be coincidental.
Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data.
The ecological data do not support a correlation between thimerosal-containing vaccines and the incidence of autism.
The role of mercury in the pathogenesis of autism
Confirmation of thimerosal as an environmental agent in autism pathogenesis has important societal and patient implications.
Thimerosal Exposure in Infants and Developmental Disorders: A Prospective Cohort Study in the United Kingdom Does Not Support a Causal Association
A large United Kingdom population–based cohort study on childhood health and development could find no convincing evidence that early exposure to thimerosal had any deleterious effect on neurologic or psychological outcome.
A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism.
  • D. Geier, M. Geier
  • Medicine
    Medical science monitor : international medical journal of experimental and clinical research
  • 2004
There was a close correlation between mercury doses from thimerosal--containing childhood vaccines and the prevalence of autism from the late 1980s through the mid-1990s and additional research be undertaken to produce a MMR vaccine with an improved safety profile.